Results 81 to 90 of about 352,837 (117)

The Impact of Serialisation on Operational Efficiency and Productivity in Irish Pharmaceutical Sites. [PDF]

Ther Innov Regul Sci
O' Mahony D, Lynch A, McDermott O.
europepmc   +1 more source

Ritual to relief: ethical frontiers in repurposing psychoactive substances. [PDF]

CNS Spectr
O'Leary E, Dodd S, Stahl S.
europepmc   +1 more source

Actor-network and stakeholder analysis in preventing health goods smuggling in Iran. [PDF]

Global Health
Meymand FM, Takian A, Jaafaripooyan E.
europepmc   +1 more source

Policy options for sustainable access to off-patent antibiotics in Europe. [PDF]

NPJ Antimicrob Resist
Panteli D, Anderson M, Fieldman T, Baraldi E, Tängdén T, Vogler S, Årdal C, Mossialos E.   +7 more
europepmc   +1 more source

Antibiotic surveillance: an action-oriented integrated approach. [PDF]

Wellcome Open Res
Valsson O, Tayler E, Kitutu FE, Bonnah J, Cornejo J, Dorado Garcia A, Dreser A, Echeverria A, Essack SY, Fenwick S, Fuller W, Hanna N, Hegewisch-Taylor J, Holloway B, Jeannin M, Joshi J, Kainga H, Khurana A, Koya SF, Larsson DGJ, Lekagul A, Lwoyero J, Masika S, Mateus ALP, Mitambo C, Moremi N, Muloi D, Ndahi M, Nkansa M, Nkhoma J, Odeo S, Ondoa P, Sharland M, Tigulini de Souza Bogo R, Sternberg-Lewerin S, Verhaegen M, Verner-Jeffreys D, Weese JS, Yamba K, Yesmin SMS, Midega J, Chandler CIR.   +41 more
europepmc   +1 more source

Approval delays in multi-country COVID-19 trials: the case of COPCOV and the risk of therapeutic inertia. [PDF]

Trials
Winters J, Schilling WH.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

European Union has the Falsified Medicines Directive

BMJ, The, 2012
Attaran and colleagues made no mention of a current important European Union directive: the so called Falsified Medicines Directive.1 …
exaly   +3 more sources

Substandard and Falsified Medicines in Myanmar

Pharmacy (Basel, Switzerland), 2020
Background: substandard and falsified medicines (SFMs) are a threat to public health. The availability of SFMs in Myanmar was reported by the World Health Organization (WHO) in 1999, but there have been few systematic surveys on falsified medicines in ...
Naoko Yoshida, Tsuyoshi Tanimoto, Mohammad Sofiqur Rahman   +2 more
exaly   +2 more sources

Regulatory Capture in Pharmaceutical Policy Making: The Case of National Medicine Agencies Related to the EU Falsified Medicines Directive

Pharmaceutical Medicine, 2019
Regulatory capture describes the phenomenon in which regulators (e.g. medical agencies) protect the interest of the companies they regulate rather than the interest of the public. Not much is known about the mechanisms of this potential threat within the area of pharmaceutical regulation.Through a comparison of two EU member states, the Netherlands and
Rasmus Borup, Janine Morgall Traulsen, Susanne Kaae   +2 more
openaire   +3 more sources

The EU Falsified Medicines Directive - A Concept for Drug Decommissioning in Hospitals.

Studies in health technology and informatics, 2019
The EU falsified Medicines Directive 2011/62/EU will be applied in Switzerland as well. It mandates unique identifiers on medication packages and a process to ensure that these identifiers are decommissioned when the medication package is handed to the patient.
Sandra, Burri, Rebecca, Scheidegger
openaire   +1 more source